Several Alliance medical specialty societies wrote to CMS Administrator Tavenner to express concerns with the proposed rule that would modify aspects of the Medicare Advantage and
Part D prescription drug program to the detriment of beneficiaries.
Several Alliance medical specialty societies wrote to CMS Administrator Tavenner to express concerns with the proposed rule that would modify aspects of the Medicare Advantage and
Part D prescription drug program to the detriment of beneficiaries.
Alliance Comments on Rule to Streamline Prior Authorization for Drugs and Improve Data Exchange June 15, 2026
Alliance Submits Letter on MACRA Reform in Advance of Congressional Hearing May 20, 2026
Alliance Newsletter: On Call Spring 2026 April 29, 2026
Alliance Supports Legislation to Modernize the Medicare Physician Fee Schedule April 24, 2026© 2026 Alliance of Specialty Medicine. All rights reserved. Website designed and developed by Orpheus, Inc..

